Susquehanna International Group
ICVX

Susquehanna International Group’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Susquehanna International Group’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,981
Closed -$220K – 13784
2023
Q4 		$220K Buy
+13,981
New +$135K ﹤0.01% 10475
2023
Q3 		– Sell
-33,853
Closed -$281K – 13293
2023
Q2 		$336K Sell
33,853
-49,683
-59% -$398K ﹤0.01% 9202
2023
Q1 		$485K Buy
+83,536
New +$722K ﹤0.01% 8651

Susquehanna International Group's ICVX Position: Q1 2024 in Review

Susquehanna International Group sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 13,981 shares — an estimated $220K sold.

Susquehanna International Group first reported a position in ICVX in Q1 2023 and held it in 3 quarters. The position peaked at $485K in Q1 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Susquehanna International Group reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 13,981 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $220K.
  • Susquehanna International Group first reported a position in Icosavax, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Susquehanna International Group's Icosavax, Inc. Common Stock position peaked at $485K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.